I was interested to read about a new drug NICE have approved for HUS which by all accounts is massively expensive.  All sorts of harrumphing followed in the press as well as the medical press about funding of expensive drugs and QALYs.  Personally I think NICE have an important yet unforgiving job to do.  I … Continue reading OSELTAMIVIR TREATMENT FOR INFLUENZA IN ADULTS: A META-ANALYSIS OF RANDOMISED CONTROLLED TRIALS (Dobson et al., 2015)